Logo BizupsLogo Bizups
    • Investors
    • Accelerators
    • Incubators
    • Startups

      Lumira Ventures

      • Home
      • Lumira Ventures
      • Posts
      Building the Future: Meet the 2024 – 2025 Lumira Venture Innovation Program (VIP) Fellows
      • Dec. 4, 2024, 2:51 p.m.

      Building the Future: Meet the 2024 – 2025 Lumira Venture …

      Congruence and Ono Announce Multi-Target Research Collaboration to Generate Small Molecule Correctors for the Treatment of Cancer
      • Dec. 3, 2024, 12:11 p.m.

      Congruence and Ono Announce Multi-Target Research Collaboration to Generate Small …

      COUR Pharmaceuticals Enters Collaboration and Licensing Agreement with Genentech to Develop and Commercialize Tolerogenic Therapy for the Treatment of an Autoimmune Disease
      • Dec. 3, 2024, 12:11 p.m.

      COUR Pharmaceuticals Enters Collaboration and Licensing Agreement with Genentech to …

      KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic and Deploy AI Tools Into Key Pipeline Indications
      • Dec. 2, 2024, 1:21 p.m.

      KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into …

      Transposon Therapeutics Strengthens and Expands Development Pipeline with the Acquisition of a Portfolio of Novel Nucleoside Analogs for Oncology
      • Nov. 25, 2024, 6:01 p.m.

      Transposon Therapeutics Strengthens and Expands Development Pipeline with the Acquisition …

      AmacaThera Exceeds Expectations with Phase 1 Results of First-in-Human Study with AMT-143, Paving the Way for a Novel Approach to Post-Operative Pain Relief
      • Nov. 20, 2024, 3:06 p.m.

      AmacaThera Exceeds Expectations with Phase 1 Results of First-in-Human Study …

      Thryv Therapeutics Appoints Esteemed Executive Leader Amy Sehnert, MD, as Chief Medical Officer
      • Nov. 20, 2024, 11:21 a.m.

      Thryv Therapeutics Appoints Esteemed Executive Leader Amy Sehnert, MD, as …

      HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
      • Nov. 18, 2024, 5:31 p.m.

      HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study

      Nocion Therapeutics Doses First Patient in ASPIRE Phase 2b Chronic Cough Study
      • Nov. 18, 2024, 5:31 p.m.

      Nocion Therapeutics Doses First Patient in ASPIRE Phase 2b Chronic …

      Thryv Therapeutics Completes Phase 1 Dosing of its Second Novel SGK1 Inhibitor THRV-1268 – Future Studies in Heart Failure and Atrial Fibrillation to Commence in 2025
      • Nov. 15, 2024, 8:46 p.m.

      Thryv Therapeutics Completes Phase 1 Dosing of its Second Novel …

      COUR Pharmaceuticals Announces Positive Top-line Results from Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
      • Nov. 11, 2024, 6:46 p.m.

      COUR Pharmaceuticals Announces Positive Top-line Results from Phase 2a Study …

      Thryv Therapeutics Receives Positive Top-Line Results from Wave I Part 2 Clinical Study in Long QT Syndrome Type 2 and Type 3 Patients
      • Nov. 11, 2024, 6:46 p.m.

      Thryv Therapeutics Receives Positive Top-Line Results from Wave I Part …

      Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment
      • Nov. 11, 2024, 6:46 p.m.

      Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in …

      COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives
      • Nov. 11, 2024, 6:46 p.m.

      COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives

        • 1
        • 2
        • 3
        • 4
        • 5
      Lumira Ventures

      Lumira Ventures

      Posts count:77

      Search Posts

      • Ontario Toronto
      • Website Lumira Ventures
      • Address: 141 Adelaide Street Suite 770 Toronto, ON Canada, M5H 3L5

      Last Posts

        Logo Bizups

        Uncover the Startup Ecosystem

        • Info@bizups.info

        Links

        • Investors
        • Accelerators
        • Incubators
        • Startups

        Links

        • Programs
        • Events
        • Mentors
        • Posts
        • Live

        Support

        • About Us
        • User Guide
        • Disclaimer
        • Privacy Policy
        • Contact Us

        Social Media

        © Bizups.info. All rights reserved.
        Login
        Sign In/Sign Up with linkedin
        Signup

        Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.

        We found a number of people with your first name. When you find your first name in this list, select it

        This section is for the registration of real people's first name, it will be canceled in case of registration with name/organization or startup profile. After registering First name, you can add and manage your startup.Entering all requested information is mandatory